Sarepta Therapeutics profit margin SRPT

Gross, operating and net profit as a share of revenue over the last twelve months, from 2017.

Net margin, 12 months: −6.9%
Net margin on a year earlier: −4.6 pts
Peer median: 10.9%

Over the twelve months to Jun 30, 2026, Sarepta Therapeutics kept −6.9% of its revenue as net profit.

The median for 10 large drugmakers of a similar size is 10.9%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal year	Net margin	Operating margin	Gross margin
FY2025	−32.5%	n/a	n/a
FY2024	12.4%	11.5%	83.2%
FY2023	−43.1%	−21.5%	87.9%
FY2022	−75.4%	−57.5%	85.0%
FY2021	−59.7%	−65.5%	86.2%
FY2020	n/a	n/a	88.3%
FY2019	n/a	n/a	85.1%
FY2018	n/a	n/a	88.6%
FY2017	−32.8%	n/a	95.2%
FY2016	n/a	n/a	n/a
FY2015	n/a	n/a	n/a
FY2014	n/a	n/a	n/a
FY2013	n/a	n/a	n/a
FY2012	n/a	n/a	n/a
FY2011	n/a	n/a	n/a

Quarter by quarter

Quarter	Ended	Net margin, 12 months	Change on a year	Operating margin
Q2 FY26	Jun 30, 2026	−6.9%	−4.6 pts	n/a
Q1 FY26	Mar 31, 2026	3.0%	+14.1 pts	n/a
Q4 FY25	Dec 31, 2025	−32.5%	−44.8 pts	n/a
Q3 FY25	Sep 30, 2025	−5.9%	−13.3 pts	−5.2%
Q2 FY25	Jun 30, 2025	−2.3%	−5.5 pts	−0.0%
Q1 FY25	Mar 31, 2025	−11.1%	−12.3 pts	−5.2%
Q4 FY24	Dec 31, 2024	12.4%	+55.5 pts	11.5%
Q3 FY24	Sep 30, 2024	7.4%	+70.0 pts	4.9%
Q2 FY24	Jun 30, 2024	3.1%	+93.6 pts	2.5%
Q1 FY24	Mar 31, 2024	1.2%	n/a	−6.8%
Q4 FY23	Dec 31, 2023	−43.1%	+32.3 pts	−21.5%
Q3 FY23	Sep 30, 2023	−62.5%	+19.2 pts	−36.1%

Against its peers

Companies in Drug Manufacturers - General nearest Sarepta Therapeutics' size, closest first, today.

Company	Profit margin
SRPTSarepta Therapeutics	−6.9%
ANIPANI Pharmaceuticals	11.1%
HRMYHarmony Biosciences	18.9%
PAHCPhibro Animal Health	6.6%
PBHPrestige Consumer Healthcare	15.6%
ANABAnaptysbio	n/m
PCRXPacira BioSciences	2.0%
NRIXNurix Therapeutics	42.0%
OMEROmeros	n/m
AMPHAmphastar Pharmaceuticals	10.8%
OGNOrganon	3.4%
Peer median	10.9%

Where Sarepta Therapeutics ranks

#44of 84Large drugmakers with the highest profit margins

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Sarepta Therapeutics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.